Fatimah I Tsiga-Ahmed

Dr. Fatimah I Tsiga-Ahmed

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2024 in Communications Medicine
Verified
Journal Article
Open access
PDF file
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
MMMuhammad Sale Musa
Muhammad Sale Musa
BMBello Tijjani Makama
Bello Tijjani Makama
ASAbdulwahab Kabir Sulaiman
Abdulwahab Kabir Sulaiman
ABAbdulaziz T. Bako
Abdulaziz T. Bako
Background: Vaccination has been recommended as one of the most potent ways of controlling the mpox (formerly, monkeypox) outbreak, particularly among high-risk groups. Here, we evaluated the prevalence of mpox vaccine acceptance and uptake globally.Methods: We searched multiple databases for peer-reviewed studies published in English from May 2022 to 25th November 2023 that evaluated mpox vaccine acceptance and/or uptake. We fit a random-effects model meta-analysis to calculate the pooled mpox vaccine acceptance and uptake rates, with their 95% confidence intervals (CI) across population outcomes. We performed subgroup analyses among the six World Health Organization (WHO) regions (Africa [AFR], Region of the Americas [AMR], South-East Asia Region [SEAR], European Region [EUR], Eastern Mediterranean Region [EMR], and the Western Pacific Region [WPR]), as well as among select population subgroups.Results: Of the 2531 studies screened, 61 studies, with a cumulative sample size of 263,857 participants from 87 countries were eligible for inclusion. The overall vaccine acceptance and uptake rates were 59.7% and 30.9% globally. Acceptance and uptake rates among the LGBTQI+ community were 73.6% vs 39.8% globally, 60.9% vs. 37.1% in AMR, 80.9% vs. 50.0% in EUR, and 75.2% vs. 33.5% in WPR. Among PLHIV, vaccine acceptance and uptake rates were 66.4% vs. 35.7% globally, 64.0% vs. 33.9% in AMR, 65.1% vs. 27.0% in EUR, and 69.5% vs. 46.6% in WPR. Among healthcare workers, vaccination intention was 51.0% globally.Conclusions: Tailored interventions are needed to bolster confidence in the mpox vaccine, maximize vaccine uptake, and increase vaccine access to close the gaps between acceptance and uptake especially among key populations residing in regions with low rates of acceptance and uptake.

6 October 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
ZIZubairu Iliyasu
Zubairu Iliyasu
AUAmina A. Umar
Amina A. Umar
HAHadiza M. Abdullahi
Hadiza M. Abdullahi
AKAminatu A. Kwaku
Aminatu A. Kwaku
TATaiwo. G. Amole
Taiwo. G. Amole
MAMuktar Hassan Aliyu
Muktar Hassan Aliyu
Vaccination is a critical tool in the global response to the COVID-19 pandemic. Yet, COVID-19 vaccine hesitancy has not been well explored in parts of Nigeria. We assessed the predictors of acceptability of the COVID-19 vaccine and identified reasons for vaccine hesitancy among adults in urban Kano, northern Nigeria. Using a mixed-methods design, we administered structured questionnaires to a cross-section of adults (n = 446), complemented with 20 in-depth interviews. Binary logistic regression and the framework approach were used to analyze the data. About one-half (51.1%, n = 228) of the respondents were willing to take the COVID-19 vaccine. Vaccine acceptance was higher among older respondents (≥30 years) (adjusted Odds Ratio (aOR) = 1.76, 95% Confidence Interval (CI): 1.14–2.99 (≥30 vs. <30), higher-income earners (≥30,000 Naira) (aOR = 2.06, 95%CI:1.12–3.80, ≥30,000 vs. <30,000), and those with a history of a chronic medical disorder (aOR = 1.90, 95%CI:1.06–3.72). Vaccine acceptance was also higher in persons with high risk perception (aOR = 1.61, 95%CI:1.13–2.81, high vs. low), those who were unconcerned about vaccine safety (aOR = 1.71, 95%CI:1.13–3.55), and those who were not worried about efficacy (aOR = 2.02, 95%CI:1.14–4.11) and infertility-related rumors (aOR = 1.98, 95%CI:1.24–3.18). Themes revealed doubts about the existence of COVID-19, mistrust for authorities, and popular credence to rumors and conspiracy theories. In conclusion, COVID-19 vaccine acceptance was sub-optimal and influenced by respondent’s age, income, co-morbidities, risk perception, and concerns about vaccine safety, efficacy, and rumors. Context-specific, evidence-based risk communication strategies and trust-building measures could boost vaccine confidence in similar settings.

30 October 2023 in Nature Human Behaviour
Verified
Journal Article
Open access
PDF file
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
MMMuhammad Sale Musa
Muhammad Sale Musa
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
ASAbdulwahab Kabir Sulaiman
Abdulwahab Kabir Sulaiman
ABAbdulaziz T. Bako
Abdulaziz T. Bako
People living with HIV (PLHIV) are at higher risk of poor outcomes of SARS-CoV-2 infection. Here we report the pooled prevalence of COVID-19 vaccine acceptance/uptake and determinants among this vulnerable population of PLHIV based on a systematic review and meta-analysis of studies published by 25 August 2023. Among the 54 included studies (N = 167,485 participants), 53 (N = 166,455) provided data on vaccine acceptance rate, while 27 (N = 150,926) provided uptake data. The global prevalences of COVID-19 vaccine acceptance and uptake were 67.0% and 56.6%, respectively. Acceptance and uptake rates were 86.6% and 90.1% for the European Region, 74.9% and 71.6% for the Region of the Americas, 62.3% and 78.9% for the South-East Asian Region, 64.6% and 19.3% for the Eastern Mediterranean Region, 58.0% and 35.5% for the African Region, and 57.4% and 44.0% for the Western Pacific Region. The acceptance rate increased from 65.9% in 2020 to 71.0% in 2022, and the uptake rate increased from 55.9% in 2021 to 58.1% in 2022. Men, PLHIV aged ≥40 years and those who had recently received the influenza vaccine were more likely to accept and receive the COVID-19 vaccine. Factors associated with lower uptake included Black race, other races (Latinx/Hispanic/mixed race), low education level and being unemployed. Vaccine-related factors associated with higher acceptance included belief in vaccine effectiveness, vaccine trust, perceived high susceptibility to SARS-CoV-2 infection and fear of potential COVID-19 effect in PLHIV. Sustained efforts and targeted interventions are needed to reduce regional disparities in COVID-19 vaccine uptake among PLHIV.

31 May 2022 in Ghana Medical Journal
Verified
Journal Article
Open access
PDF file
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
RJRabiu I. Jalo
Rabiu I. Jalo
UIUsman M. Ibrahim
Usman M. Ibrahim
AKAminatu A. Kwaku
Aminatu A. Kwaku
AUAmina A. Umar
Amina A. Umar
TATaiwo G. Amole
Taiwo G. Amole
Objectives: We estimated the length-of-stay (LOS) in the health facility after childbirth and identified associated factors in three sub-Saharan African countries.Design: Secondary analysis using data from the most recent Multiple Indicator Cluster Surveys.Setting: Multiple Indicator Cluster Surveys from Ghana, Malawi and Eswatini were selected.Participants: Women aged 15-49 years who had a facility delivery in the two years preceding the survey were in-cluded.Main outcome measures: Length-of-stay recorded in days and weeks were converted to hours and analysed as a continuous variable.Results: Length-of-stay was estimated for 9147 women, wherein 6610 women (median LOS and IQR: 36 36,60 hours), 1698 women (median LOS and IQR 36 10,60 hours) and 839 women (median-length-stay 36 36,60 hours) were from Malawi, Ghana and Eswatini respectively. Being from Ghana [RC, -20.6 (95%CI:-25.2 - -16.0)] and then Eswatini [RC: -13.0 (95%CI: -19.9 - -9.8)] and delivery in a government hospital [RC: -4.9 (95%CI -9.9- -0.3)] were independently associated with having a shorter LOS. Having a caesarean section, assistance by Nurses/Mid-wives or Auxiliaries/CHOs, single birth, heavier birth weight, and death of newborn before discharge increased the duration of stay.Conclusions: Necessitating and facility factors are important determinants of length of stay. Socio-demographic characteristics, however, have a restricted role in influencing the duration of postpartum stay in sub-Saharan Africa. Further prospective research is required to identify more determinants and provide evidence for policy formulation and clinical guidelines regarding the safest time for discharge after delivery.

SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
MoezAlIslam Ezzat FarisMoezAlIslam Ezzat Faris
MoezAlIslam Ezzat Faris
MMMuhammad Sale Musa
Muhammad Sale Musa
AUABASI-OKOT UDOYEN
ABASI-OKOT UDOYEN
Moien AB KhanMoien AB Khan
Moien AB Khan
The Islamic month of Ramadan is marked by fasting, when Muslims refrain from eating and drinking from dawn to sunset, which has an impact on their dietary habits. The study aimed to assess Nigerian Muslims’ dietary modifications during Ramadan and their related changes in body weight and health status. A web-based cross-sectional study was conducted among Nigerian adult Muslims. The survey assessed sociodemographic, dietary habits, eating behaviors, food choices, perceived weight changes, and health status. The logistic regression model was used to assess the predictors of weight change and perceived health status. There were 770 participants, 62.9% of whom were women, ranging in age from 18 to 60 years with a mean age of 27.7 ± 6.4 years. Fruits, palm dates, homemade foods, milk products, and vegetables were more frequently consumed. There were fewer energy drinks, pastries, salty snacks, and carbonated or sugared drinks consumed during Ramadan than before. Over half (54.6%, 95% CI: 51.0–58.9%) of the respondents lost weight during Ramadan, 37.0% (95% CI: 17.4–38.6%) maintained their weight and 8.4% (95% CI: 6.6–10.6%) gained weight during the month. Nearly all (97.3%, 95% CI: 95.8–98.3%) reported having good health during Ramadan, and 2.7% (95% CI: 1.7–4.1%) reported having a poorer health state during Ramadan. There was a significant weight loss and healthy dietary change associated with Ramadan fasting in Nigeria. Public health measures must be in place to impart such positive health behaviors so that such healthy habits continue throughout the year.

10 September 2024 in npj Women's Health
Verified
Journal Article
Open access
PDF file
FTFatimah I Tsiga-Ahmed
Fatimah I Tsiga-Ahmed
MUMusa Usman Umar
Musa Usman Umar
AAAishatu Lawal Adamu
Aishatu Lawal Adamu
SSSahabi Kabir Sulaiman
Sahabi Kabir Sulaiman
AGAmole Taiwo Gboluwaga
Amole Taiwo Gboluwaga
HGHadiza Shehu Galadanci
Hadiza Shehu Galadanci
The burden of postpartum depression (PPD), an important but largely neglected cause of maternal morbidity, is often increased by the presence of common co-morbidities, such as postpartum haemorrhage (PPH). Additionally, stress and the absence of social support can amplify PPD risk. Understanding the relationship between these conditions will help identify at-risk women and allow prompt intervention. Using a prospective cohort design, we recruited 72 women who had experienced PPH and another 72 women who had not within 24 h of delivery to assess the risk of PPD among them. The cumulative incidence of PPD among all participants was 15.3% (19/124). There was insufficient evidence to suggest that women with PPH have a higher risk of PPH than women without PPH (OR: 1.32; 95% CI: 0.55–3.13). Poor social support and high perceived stress increased the risk of PPD. We recommend screening for PPD among women with high perceived stress and low social support.